- Home
- BSET vs SPRO Comparison
BSET vs SPRO Comparison
Compare BSET & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSET
- SPRO
- Stock Information
- Founded
- BSET 1902
- SPRO 2013
- Country
- BSET United States
- SPRO United States
- Employees
- BSET N/A
- SPRO N/A
- Industry
- BSET Home Furnishings
- SPRO Biotechnology: Pharmaceutical Preparations
- Sector
- BSET Consumer Discretionary
- SPRO Health Care
- Exchange
- BSET Nasdaq
- SPRO Nasdaq
- Market Cap
- BSET 138.2M
- SPRO 128.9M
- IPO Year
- BSET 1987
- SPRO 2017
- Fundamental
- Price
- BSET $15.24
- SPRO $2.21
- Analyst Decision
- BSET
- SPRO Buy
- Analyst Count
- BSET 0
- SPRO 4
- Target Price
- BSET N/A
- SPRO $5.00
- AVG Volume (30 Days)
- BSET 33.7K
- SPRO 450.2K
- Earning Date
- BSET 10-08-2025
- SPRO 11-13-2025
- Dividend Yield
- BSET 5.25%
- SPRO N/A
- EPS Growth
- BSET N/A
- SPRO N/A
- EPS
- BSET 0.90
- SPRO N/A
- Revenue
- BSET $330,953,000.00
- SPRO $48,576,000.00
- Revenue This Year
- BSET $3.16
- SPRO N/A
- Revenue Next Year
- BSET $3.59
- SPRO N/A
- P/E Ratio
- BSET $17.00
- SPRO N/A
- Revenue Growth
- BSET N/A
- SPRO N/A
- 52 Week Low
- BSET $13.58
- SPRO $0.51
- 52 Week High
- BSET $19.75
- SPRO $3.22
- Technical
- Relative Strength Index (RSI)
- BSET 41.06
- SPRO 53.72
- Support Level
- BSET $15.29
- SPRO $1.84
- Resistance Level
- BSET $15.86
- SPRO $2.52
- Average True Range (ATR)
- BSET 0.62
- SPRO 0.12
- MACD
- BSET -0.04
- SPRO 0.03
- Stochastic Oscillator
- BSET 3.15
- SPRO 56.62
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About SPRO Spero Therapeutics Inc.
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.